Latest Blogs

Guest Commentary
Jun 25, 2019
We Must Vaccinate Our Most Vulnerable Patients Against the Most Preventable Diseases
As a physician and future pediatric oncologist, Dr. Rachel Offenbacher believes that providers have the responsibility to be vocal about the critical importance of vaccines.
Don S. Dizon, MD, FACP, FASCO
Jun 25, 2019
Caring for Transgender Patients With Cancer
We owe it to this vulnerable population to check our assumptions and deliver the highest-quality cancer care in a safe and welcoming environment.
Edward Paul Balaban, DO, FACP, FASCO
Jun 20, 2019
ASCO’s Delegation at the AMA House of Delegates: So Much More to Do
Key cancer-related topics discussed at the AMA-HOD meeting included alcohol ingestion as a causation risk factor, appropriate guidelines for opioids in the cancer setting, and the use of de-identified patient information.
Guest Commentary
Jun 19, 2019
Continuing the Dialogue With Patients in Mind: Two Oncologists Reflect On #ASCO19
"We believe what mattered the most about #ASCO19 is that patients were part of the discussion," write Dr. Mark A. Lewis and Dr. Chadi Nabhan.
Subscribe to this column

International Perspectives

International Perspectives provides an interactive platform for international leaders in their respective fields to share perspectives on oncology topics. International Perspectives contributors are invited to post by invitation from ASCO’s volunteer leadership and key staff.

Feb 02, 2015
Choosing Healthy Lives Can Prevent One-Third of Cancer Deaths
By Ian N. Olver, MD, PhD, FRACP. One-third of cancer deaths could be prevented by lifestyle choices alone. If there was a drug that claimed that success, it would be front page news. Changing behavior doesn’t seem dramatic, yet can be very difficult to achieve. The three areas in which the most...
Feb 02, 2015
Delivering Early Detection
By Sana Al Sukhun, MD, MSc, President of Jordan Oncology Society. Early detection has become the motto of public health campaigns all over the world. Not only does it reduce the burden of disease by reducing morbidity (complications of both disease and treatment), but also by reducing associated...
Feb 02, 2015
Achieving Treatment for All
By Paul Ruff, MD, University of Witwatersrand, Johannesburg, South Africa. Since the turn of the century, we have seen a paradigm shift in the way we treat cancer, with the advent of targeted therapies, especially monoclonal antibodies and small molecule kinase inhibitors. Indeed the development of...
1 Comments
Nov 18, 2014
The International Clinical Trials Workshop (ICTW) Debuts in South Central Asia
Tanja Cufer, MD, PhDASCO International Clinical Trials Workshop (ICTW) Working Group Chair    Dr. Tanja Cufer presents at the International Clinical Trials 
Sep 23, 2014
Letter from the International Affairs Committee Chair: Reflections from the Committee Meeting
By Yun Yen, MD, PhD, City of Hope
Jul 08, 2014
Efficient Teamwork at Tumor Boards
 By Nagi S. El Saghir, MD, FACPImmediate Past Chair, ASCO International Affairs CommitteeProfessor and Director, Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon

Pages